XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients

Author:

Seibold Petra,Behrens Sabine,Schmezer Peter,Helmbold Irmgard,Barnett Gillian,Coles Charlotte,Yarnold John,Talbot Christopher J.,Imai Takashi,Azria David,Koch C. Anne,Dunning Alison M.,Burnet Neil,Bliss Judith M.,Symonds R. Paul,Rattay Tim,Suga Tomo,Kerns Sarah L.,Bourgier Celine,Vallis Katherine A.,Sautter-Bihl Marie-Luise,Claßen Johannes,Debus Juergen,Schnabel Thomas,Rosenstein Barry S.,Wenz Frederik,West Catharine M.,Popanda Odilia,Chang-Claude Jenny

Funder

Dietmar Hopp Stiftung

Deutsche Krebshilfe

Federal Office for Radiation Protection

US Army Medical Research and Materiel Command (USAMRMC)

Breast Cancer Research Program (BCRP)

National Institute of Radiological Sciences (NIRS)

Canadian Institutes of Health Research

Novartis Oncology France.

Breast Cancer Campaign

Cancer Research UK

Experimental Cancer Medicine funding

National Institute for Health Research (NIHR) Biomedical Research Centre

National Health Service (NHS)

Institute of Cancer Research UK

American Cancer Society

Department of Defense

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3